2m 2m 2m 2m 2m 2m 2m
BIONANO GENOM (BNGO)
NASDAQ
$1.17+$0.02 (+1.30%)
Price as of Jun 23, 2026 7:08 PM EDT- $13.2MMarket Cap
- -64.83%1-Year Change
- Medical Instruments & SuppliesIndustry
BIONANO GENOM (BNGO)
$1.17+$0.02 (+1.30%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 26.7M -0.98% | 27.0M -25.22% | 36.1M +29.90% | 27.8M +54.62% | |
Cost of Revenue | 14.4M -49.28% | 28.4M +7.15% | 26.6M +21.47% | 21.9M +54.94% | |
Gross Profit | 12.3M +954.55% | -1.4M -115.06% | 9.6M +60.91% | 5.9M +53.46% | |
Sales and Marketing Expense | 35.1M -32.21% | 51.9M -44.54% | 93.5M +5.53% | 88.6M +51.47% | |
Research and Development Expense | -11.4M -54.14% | -24.8M -54.10% | -54.0M +10.16% | -49.0M +118.13% | |
Depreciation and Amortization Expense | 9.5M -32.06% | 14.0M +2.29% | 13.7M +42.48% | 9.6M +187.11% | |
Total Operating Expenses | 46.5M -55.42% | 104.4M -53.58% | 224.8M +63.33% | 137.6M +69.98% | |
Operating Profit | -33.3M -67.94% | -104.0M -51.69% | -215.2M +63.44% | -131.7M +70.81% | |
Interest Income | 1.0M -33.33% | 1.5M -54.55% | 3.3M +120.00% | 1.5M +275.00% | |
Interest Expense | -298,000 +3.11% | -289,000 -94.35% | -5.1M +1,617.79% | -298,000 -67.85% | |
Interest Income and Expense and Net | 702,000 -42.03% | 1.2M +166.58% | -1.8M -251.33% | 1.2M +328.08% | |
Total Nonoperating Income and Expense | 7.0M +187.63% | -8.0M -53.44% | -17.2M -1,843.00% | 986,000 +193.82% | |
Income before Taxes | -26.3M -76.49% | -112.0M -51.82% | -232.4M +77.82% | -130.7M +67.25% | |
Income Taxes | 67,000 +103.03% | 33,000 -46.77% | 62,000 -96.71% | 1.9M +132.95% | |
Extraordinary Items | 0 -100.00% | 19.7M N/A | N/A N/A | N/A N/A | |
Net Income | -26.4M -76.44% | -112.0M -51.82% | -232.5M +75.34% | -132.6M +83.06% | |
Net Income from Continuing Operations Applicable to Common | -26.3M -76.49% | -112.0M -51.82% | -232.4M +77.82% | -130.7M +67.25% | |
Basic EPS and Net Income | -4.85 -94.50% | -88.13 +1,194.13% | -6.81 +1,380.43% | -0.46 +76.92% | |
Diluted EPS and Net Income | -4.85 -94.50% | -88.13 +1,194.13% | -6.81 +1,380.43% | -0.46 +76.92% | |
Basic Weighted Average Shares | 5.4M +328.40% | 1.3M -96.28% | 34.1M -88.19% | 289.2M +4.49% | |
Diluted Weighted Average Shares | 5.4M +328.40% | 1.3M -96.28% | 34.1M -88.19% | 289.2M +4.49% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.0M -67.40% | 9.2M -48.89% | 17.9M +252.54% | 5.1M -79.28% | |
Short-Term Investments | 16.3M +5,290.40% | 302,000 -99.38% | 48.8M -54.83% | 108.1M -52.18% | |
Cash and Cash Equivalents and Short-Term Investments | 19.3M +103.37% | 9.5M -85.81% | 66.8M -41.01% | 113.2M -54.84% | |
Total Current Assets | 45.4M +14.93% | 39.5M -71.82% | 140.1M -10.92% | 157.3M -42.26% | |
Accumulated Depreciation | 28.2M +4.98% | 26.9M +40.81% | 19.1M +45.88% | 13.1M +44.15% | |
Property and Plant and Equipment and Net | 14.8M -22.75% | 19.2M -17.67% | 23.3M +29.49% | 18.0M +74.73% | |
Total Long-Term Assets | 2.7M -2.18% | 2.8M -62.94% | 7.4M +207.83% | 2.4M +222.30% | |
Total Assets | 73.6M -4.03% | 76.7M -64.24% | 214.4M -30.28% | 307.5M -18.46% | |
Income Taxes Payable | 272,000 -88.24% | 2.3M +110.46% | 1.1M +33.21% | 825,000 +21.86% | |
Total Short-Term Debt | 19.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 22.9M -38.57% | 37.3M -62.67% | 100.0M +178.75% | 35.9M +64.30% | |
Total Long-Term Debt | 30.2M -14.72% | 35.4M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 2.7M +564.56% | 412,000 -89.00% | 3.7M -33.51% | 5.6M +3.63% | |
Total Liabilities | 29.2M -29.39% | 41.3M -65.08% | 118.2M +103.51% | 58.1M +45.33% | |
Retained Earnings | -719.6M +3.81% | -693.2M +19.27% | -581.2M +66.67% | -348.7M +61.35% | |
Total Stockholders Equity | 44.4M +25.58% | 35.4M -63.21% | 96.2M -61.44% | 249.4M -26.02% | |
Total Shares Outstanding | 10.7M +475.76% | 1.9M -95.92% | 45.8M -84.60% | 297.2M +2.62% | |
Cash Flow | |||||
Cash from Operating Activities | -16.3M -76.28% | -68.9M -44.94% | -125.2M +0.29% | -124.8M +73.53% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -12.7M -117.26% | 73.8M +205.65% | 24.2M -70.81% | 82.8M +129.77% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 24.0M +275.66% | -13.7M -112.02% | 113.8M +394.70% | 23.0M -93.15% | |
Financials Ratio | |||||
Gross Margin | 46.05% +963.01% | -5.34% -120.14% | 26.49% +23.87% | 21.38% -0.75% | |
Operating Margin | -124.66% -67.62% | -385.01% -35.40% | -595.98% +25.81% | -473.70% +10.47% | |
Return on Assets | -35.13% -54.35% | -76.97% -13.61% | -89.09% +130.00% | -38.74% +17.00% | |
Return on Equity | -66.15% -61.16% | -170.33% +26.58% | -134.56% +197.61% | -45.21% +16.17% | |
Revenue Growth | -0.98% -96.11% | -25.22% -184.33% | 29.90% -45.25% | 54.62% -51.00% | |
Current Ratio | 1.98 +87.09% | 1.06 -24.51% | 1.40 -68.04% | 4.38 -64.86% | |
Cash Ratio | 0.13 -46.95% | 0.25 +36.90% | 0.18 +26.43% | 0.14 -87.39% | |
Debt-to-Equity Ratio | 1.12 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.68 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow